1
|
Oliveira Rocha AM, Severo Sabedra Sousa F, Mascarenhas Borba V, S Munchen T, Guerin Leal J, Dorneles Rodrigues OE, G Fronza M, Savegnago L, Collares T, Kömmling Seixas F. Evaluation of the effect of synthetic compounds derived from azidothymidine on MDA-MB-231 type breast cancer cells. Bioorg Med Chem Lett 2020; 30:127365. [PMID: 32738968 DOI: 10.1016/j.bmcl.2020.127365] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 06/19/2020] [Accepted: 06/20/2020] [Indexed: 12/19/2022]
Abstract
The present study aimed to investigate the effect of AZT derivates containing tellurium (Te) on human breast cancer cell lines and the mechanisms underlying cell death. The inhibitory effect of AZT and its derivatives (7m and 7r) was determined by the MTT assay (6.25, 12.5, 25, 50 and 100 μM in 24 and 48 h time points), meanwhile the induction of apoptosis and the cell cycle phases was investigated by flow cytometry. The MTT assay showed that AZT derivatives decreased the rate of cell proliferation at concentrations of 12.5 μM, while commercial AZT showed low antitumor potential. In flow cytometric analysis, we demonstrate that the AZT derivatives do not induce apoptosis at the concentration tested and promote the cell cycle arrest in the S phase. Besides, predicted absorption, distribution, metabolization, excretion and toxicity analysis suggest that the compounds possess a good pharmacokinetic profile and possibly less toxicity when compared to conventional AZT. These compounds containing tellurium in their formulation are potential therapeutic agents for breast cancer.
Collapse
Affiliation(s)
- Adriely Maria Oliveira Rocha
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Fernanda Severo Sabedra Sousa
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Victoria Mascarenhas Borba
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Taiana S Munchen
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Julliano Guerin Leal
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Oscar Endrigo Dorneles Rodrigues
- Department of Biochemistry and Molecular Biology, Center for Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Mariana G Fronza
- Postgraduate Program in Biotechnology (PPGB), Neurobiotechnology Research Group, Technological Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Postgraduate Program in Biotechnology (PPGB), Neurobiotechnology Research Group, Technological Development Center, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Tiago Collares
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Fabiana Kömmling Seixas
- Postgraduate Program in Biotechnology (PPGB), Research Group on Cellular and Molecular Oncology - GPO, Center for Technological Development, Federal University of Pelotas, Pelotas, RS, Brazil.
| |
Collapse
|